These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 8864539
1. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites. Escribá PV, Alemany R, Sastre M, Olmos G, Ozaita A, García-Sevilla JA. Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539 [Abstract] [Full Text] [Related]
2. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Escribá PV, Ozaita A, García-Sevilla JA. Ann N Y Acad Sci; 1999 Jun 21; 881():8-25. PubMed ID: 10415892 [Abstract] [Full Text] [Related]
3. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Olmos G, Alemany R, Escriba PV, García-Sevilla JA. Br J Pharmacol; 1994 Apr 21; 111(4):997-1002. PubMed ID: 8032628 [Abstract] [Full Text] [Related]
4. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Alemany R, Olmos G, García-Sevilla JA. Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 21; 356(1):39-47. PubMed ID: 9228188 [Abstract] [Full Text] [Related]
5. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R, Olmos G, García-Sevilla JA. Br J Pharmacol; 1995 Feb 21; 114(4):837-45. PubMed ID: 7773544 [Abstract] [Full Text] [Related]
6. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Boronat MA, Olmos G, García-Sevilla JA. Br J Pharmacol; 1998 Sep 21; 125(1):175-85. PubMed ID: 9776358 [Abstract] [Full Text] [Related]
7. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA. Br J Pharmacol; 1997 Jul 21; 121(5):901-12. PubMed ID: 9222546 [Abstract] [Full Text] [Related]
8. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA. J Pharmacol Exp Ther; 1993 Mar 21; 264(3):1187-97. PubMed ID: 8095548 [Abstract] [Full Text] [Related]
9. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase. Renouard A, Widdowson PS, Cordi A. Br J Pharmacol; 1993 Jul 21; 109(3):625-31. PubMed ID: 8102932 [Abstract] [Full Text] [Related]
11. Modulation of catecholamine release by alpha 2-adrenoceptors and I1-imidazoline receptors in rat brain. Meana JJ, Herrera-Marschitz M, Goiny M, Silveira R. Brain Res; 1997 Jan 09; 744(2):216-26. PubMed ID: 9027381 [Abstract] [Full Text] [Related]
12. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo. Miralles A, Ribas C, Olmos G, García-Sevilla JA. J Neurochem; 1993 Nov 09; 61(5):1602-10. PubMed ID: 8228980 [Abstract] [Full Text] [Related]
15. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system. Hussain JF, Kendall DA, Wilson VG. Br J Pharmacol; 1993 Jul 09; 109(3):831-7. PubMed ID: 8102937 [Abstract] [Full Text] [Related]
19. Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Sastre M, García-Sevilla JA. Neurochem Int; 1997 Jan 09; 30(1):63-72. PubMed ID: 9116589 [Abstract] [Full Text] [Related]